$231 Million is the total value of JW Asset Management, LLC's 15 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 90.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ESTA | ESTABLISHMENT LABS HLDGS INC | $156,655,239 | -28.5% | 3,192,485 | 0.0% | 67.85% | -14.9% | |
CELH | Buy | CELSIUS HLDGS INC | $17,160,000 | +26.3% | 100,000 | +9.8% | 7.43% | +50.4% |
LLY | ELI LILLY & CO | $14,502,510 | +14.5% | 27,000 | 0.0% | 6.28% | +36.4% | |
NVO | Buy | NOVO-NORDISK A Sadr | $10,749,108 | +12.4% | 118,200 | +100.0% | 4.66% | +33.8% |
New | VITA COCO CO INC | $8,999,971 | – | 345,621 | +100.0% | 3.90% | – | |
CPRX | CATALYST PHARMACEUTICALS INC | $6,586,052 | -13.0% | 563,392 | 0.0% | 2.85% | +3.6% | |
NVDA | New | NVIDIA CORPORATION | $6,524,850 | – | 15,000 | +100.0% | 2.83% | – |
TSLA | New | TESLA INC | $2,627,310 | – | 10,500 | +100.0% | 1.14% | – |
HRTX | Buy | HERON THERAPEUTICS INC | $2,479,641 | -3.2% | 2,407,418 | +9.1% | 1.07% | +15.2% |
IDAHO STRATEGIC RESOURCES | $1,369,353 | -5.6% | 271,697 | 0.0% | 0.59% | +12.3% | ||
CAT | New | CATERPILLAR INC | $1,098,552 | – | 4,024 | +100.0% | 0.48% | – |
ETN | New | EATON CORP PLC | $1,066,400 | – | 5,000 | +100.0% | 0.46% | – |
FAZE HOLDINGS INC | $518,344 | -66.4% | 3,126,319 | 0.0% | 0.22% | -59.9% | ||
CRON | New | CRONOS GROUP INC | $400,000 | – | 200,000 | +100.0% | 0.17% | – |
HITI | New | HIGH TIDE INC | $138,750 | – | 75,000 | +100.0% | 0.06% | – |
MSOS | Exit | ADVISORSHARES TRpure us cannabis | $0 | – | -300,000 | -100.0% | -0.60% | – |
HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -50,673 | -100.0% | -1.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-09
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 92.3% |
ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-09 |
4 | 2024-01-02 |
SC 13D/A | 2024-01-02 |
4 | 2023-12-26 |
4 | 2023-12-19 |
4 | 2023-12-12 |
4 | 2023-12-07 |
4 | 2023-12-06 |
4 | 2023-11-21 |
4 | 2023-11-20 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.